25 research outputs found

    Early foetal development of the articular disc in the human temporomandibular joint

    Get PDF
    In foetuses of 9 and 10 weeks the articular disc presents a more cellular structure with bands of connective tissue fibres. It is connected with the articular capsule and lateral pterygoid muscle. During weeks 11 and 12 there is an increase in collagenous fibres and fusiform cells are located mainly close to the surface of the disc

    Combined Boyden-Flow Cytometry Assay Improves Quantification and Provides Phenotypification of Leukocyte Chemotaxis

    Get PDF
    Chemotaxis has been studied by classical methods that measure chemotactic and random motility responses in vitro, but these methods do not evaluate the total number and phenotype of migrating leukocytes simultaneously. Our objective was to develop and validate a novel assay, combined Boyden-flow cytometry chemotaxis assay (CBFCA), for simultaneous quantification and phenotypification of migrating leukocytes. CBFCA exhibited several important advantages in comparison to the classic Boyden chemotaxis assay (CBCA): 1) improved precision (intra-assay coefficients of variation (CVs): CBFCA-4.7 and 4.8% vs. CBCA-30.1 and 17.3%; inter-observer CVs: CBFCA-3.6% vs. CBCA 30.1%); 2) increased recovery of cells, which increased assay to provide increased sensitivity; 3) high specificity for determining the phenotype of migrating/attracted leukocytes; and 4) reduced performance time (CBFCA 120 min vs. CBCA 265 min). Other advantages of CBFCA are: 5) robustness, 6) linearity, 7) eliminated requirement for albumin and, importantly, 8) enabled recovery of migrating leukocytes for subsequent studies. This latter feature is of great benefit in the study of migrating leukocyte subsets. We conclude that the CBFCA is a novel and improved technique for experiments focused on understanding leukocyte trafficking during the inflammatory response

    Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

    Get PDF
    Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049

    Frictional resistance exerted by different lingual and labial brackets: an in vitro study

    No full text
    Background: Although much has been written on the implications of friction generated between orthodontic archwires and labial brackets, information on lingual brackets is still limited. Hence, we set out to investigate the frictional resistance exerted by different lingual and labial brackets, including both conventional and self-ligating designs. The effect of various factors, namely bracket/base width, slot size, inter-bracket distance, and first- (ΘcI) and second-order (ΘcII) critical contact angles were evaluated and compared. Methods: A plaster model of a pretreatment oral cavity was replicated to provide 18 (9 upper and 9 lower) identical versions. The anterior segments of each were taken, and the canine and lateral and central incisors were mounted with either lingual (7th Generation, STb, New STb, In-Ovation L, ORJ) or labial (Mini-Mono, Mini Diamond, G&H Ceramic) brackets. Mechanical friction tests were performed on each type of bracket using a universal testing machine. The maximum force necessary to displace NiTi wires of two different diameters (0.012, 0.014) was measured, using both elastic and metal ligatures with conventional brackets. Results: The frictional force necessary to displace the wires increased as the diameter of the wire increased in all tested brackets (p < 0.01). Friction was significantly higher (p < 0.001) with elastic ligatures, as compared with metal ones, in all conventional brackets. In the lower lingual group, significantly lower friction was generated at conventional lingual New STb brackets (p < 0.01) and ORJ lingual brackets (p < 0.05) than at self-ligating In-Ovation L lingual brackets. A significant statistical correlation between (ΘcI) and friction was detected in the lower labial bracket group. Conclusions: Friction resistance is influenced not only by the bracket type, type of ligation, and wire diameter but also by geometric differences in the brackets themselves

    Influence of acute renal failure on the mononuclear phagocytic system

    No full text
    Several studies show the ability of macrophages to remove particles injected into the bloodstream. This function seems to be increased in the presence of acute renal failure. The objective of the present study was to assess the phagocytic function of the main organs (spleen, liver and lung) of the mononuclear phagocytic system in renal and postrenal failures. Fifteen rats (250-350 g) were divided into three groups (N = 5): group I - control; group II - ligature of both ureters, and group III - bilateral nephrectomy. On the third postoperative day, all animals received an iv injection of 1 ml/kg 99mTc sulfur colloid. Blood samples were collected for the assessment of plasma urea, creatinine, sodium, and potassium concentrations and arterial gasometry. Samples of liver, spleen, lung and blood clots were obtained and radioactivity was measured. Samples of liver, spleen, lung and kidney were prepared for routine histopathological analysis. Plasma urea, creatinine and potassium concentrations in groups II and III were higher than in group I (P<0.05). Plasma sodium concentrations in groups II and III were lower than in group I (P<0.05). Compensated metabolic acidosis was observed in the presence of postrenal failure. Group II animals showed a lower level of radioactivity in the spleen (0.98) and lung (2.63), and a higher level in the liver (105.51) than control. Group III animals showed a lower level of radioactivity in the spleen (11.94) and a higher level in the liver (61.80), lung (11.30) and blood clot (5.13) than control. In groups II and III liver steatosis and bronchopneumonia were observed. Renal and postrenal failures seem to interfere with blood clearance by the mononuclear phagocytic system
    corecore